| TELO Stock | | | CAD 0.11 0.01 8.33% |
Founder
Sabine Mai is Interim Founder of Telo Genomics Corp since 2018.
| Tenure | 6 years |
| Address | MaRS Centre, Toronto, ON, Canada, M5G 1L7 |
| Phone | 416 673 8487 |
| Web | https://www.telodx.com |
Telo Genomics Management Efficiency
The company has return on total asset
(ROA) of
(0.8732) % which means that it has lost $0.8732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(1.6942) %, meaning that it generated substantial loss on money invested by shareholders. Telo Genomics' management efficiency ratios could be used to measure how well Telo Genomics manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to climb to -0.12 in 2024.
Return On Capital Employed is likely to climb to -0.13 in 2024. At this time, Telo Genomics'
Total Assets are fairly stable compared to the past year.
Total Current Assets is likely to climb to about 3.4
M in 2024, whereas
Intangible Assets are likely to drop slightly above 520.3
K in 2024.
Telo Genomics Corp has accumulated 32.5
K in total debt. Telo Genomics Corp has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Telo Genomics until it has trouble settling it off, either with new capital or with free cash flow. So, Telo Genomics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telo Genomics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telo to invest in growth at high rates of return. When we think about Telo Genomics' use of debt, we should always consider it together with cash and equity.
Telo Genomics Corp., a personalized medicine company, focuses on the development and commercialization of predictive technological products. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. TELO GENOMICS operates under Diagnostics Research classification in Canada and is traded on TSX Venture Exchange. Telo Genomics Corp (TELO) is traded on TSX Venture Exchange in Canada and employs 3 people. Telo Genomics is listed under Biotechnology category by Fama And French industry classification.
Management Performance
Telo Genomics Corp Management Team
Elected by the shareholders, the Telo Genomics' board of directors comprises two types of representatives: Telo Genomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Telo. The board's role is to monitor Telo Genomics' management team and ensure that shareholders' interests are well served. Telo Genomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Telo Genomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Telo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Telo Genomics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to
measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to
predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.